Total Payments
$366.53
2023 Payments
$61.77
Companies
3
Transactions
15
Medicare Patients
2,445
Medicare Billing
$184,465
Payment Breakdown by Category
Food & Beverage$352.41 (96.1%)
Education$14.12 (3.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $352.41 | 14 | 96.1% |
| Education | $14.12 | 1 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $196.17 | 6 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $156.24 | 8 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $14.12 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $61.77 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($41.77) |
| 2022 | $140.54 | 6 | Novo Nordisk Inc ($87.03) |
| 2021 | $164.22 | 6 | Novo Nordisk Inc ($89.14) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/14/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), STIOLTO RESPIMAT | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: RESPIRATORY | ||||||
| 07/13/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Diabetes | ||||||
| 12/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: RESPIRATORY | ||||||
| 10/06/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: RESPIRATORY | ||||||
| 07/21/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Diabetes | ||||||
| 06/01/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $59.22 | General |
| Category: Diabetes | ||||||
| 03/24/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: RESPIRATORY | ||||||
| 01/27/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Diabetes | ||||||
| 11/24/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Education | In-kind items and services | $14.12 | General |
| Category: Cardiovascular | ||||||
| 11/18/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: RESPIRATORY | ||||||
| 08/05/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: RESPIRATORY | ||||||
| 05/12/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $75.21 | General |
| Category: Diabetes | ||||||
| 04/29/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: RESPIRATORY | ||||||
| 04/01/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 468 | 552 | $190,294 | $33,748 |
| 2022 | 16 | 706 | 1,678 | $263,774 | $59,524 |
| 2021 | 12 | 705 | 883 | $276,762 | $54,758 |
| 2020 | 9 | 566 | 727 | $223,743 | $36,435 |
Total Patients
2,445
Total Services
3,840
Medicare Billing
$184,465
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 220 | $97,720 | $12,360 | 12.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 68 | 68 | $33,164 | $7,041 | 21.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $18,420 | $5,916 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 97 | $28,423 | $3,956 | 13.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 26 | 27 | $5,330 | $1,929 | 36.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 28 | $1,478 | $810.04 | 54.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $1,170 | $578.60 | 49.5% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 14 | 14 | $1,288 | $539.98 | 41.9% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 12 | 12 | $1,075 | $462.84 | 43.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 19 | $2,227 | $154.02 | 6.9% |
| 91312 | Sarscov2 vac bvl 30mcg/0.3ml | Office | 2023 | 14 | 14 | $0.14 | $0.14 | 100.0% |
| 91313 | Sarscov2 vac bvl 50mcg/0.5ml | Office | 2023 | 12 | 12 | $0.12 | $0.12 | 100.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 174 | 276 | $118,358 | $16,358 | 13.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 11 | 840 | $24,150 | $14,341 | 59.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 91 | 91 | $43,470 | $9,638 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 111 | $31,797 | $5,242 | 16.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 60 | 62 | $11,833 | $4,239 | 35.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 17 | 17 | $11,999 | $2,294 | 19.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 12 | $8,780 | $2,164 | 24.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 63 | 65 | $3,735 | $1,818 | 48.7% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 29 | 29 | $2,262 | $1,075 | 47.5% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 24 | 24 | $1,872 | $889.92 | 47.5% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 23 | 23 | $1,735 | $857.78 | 49.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $686.00 | $337.10 | 49.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 32 | $3,098 | $268.86 | 8.7% |
About Annette Kaminsky, APNP
Annette Kaminsky, APNP is a Nurse Practitioner healthcare provider based in Manitowoc, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831184142.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Annette Kaminsky, APNP has received a total of $366.53 in payments from pharmaceutical and medical device companies, with $61.77 received in 2023. These payments were reported across 15 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($352.41).
As a Medicare-enrolled provider, Kaminsky has provided services to 2,445 Medicare beneficiaries, totaling 3,840 services with total Medicare billing of $184,465. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Manitowoc, WI
- Active Since 09/13/2005
- Last Updated 07/12/2007
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1831184142
Products in Payments
- STIOLTO RESPIMAT (Drug) $138.12
- RYBELSUS (Drug) $75.21
- Ozempic (Drug) $73.15
- Rybelsus (Drug) $47.81
- SPIRIVA RESPIMAT (Drug) $18.12
- ELIQUIS (Drug) $14.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Manitowoc
Melissa Leist, Anp-C, ANP-C
Nurse Practitioner — Payments: $3,198
Nurse Practitioner $3,198
Kimberly Williams, Np, NP
Nurse Practitioner — Payments: $2,787
Nurse Practitioner $2,787
Sarah O'rourke, Np, NP
Nurse Practitioner — Payments: $391.94
Nurse Practitioner $391.94
Zoualia Vang, Dnp, Apnp, Np-C, DNP, APNP, NP-C
Nurse Practitioner — Payments: $338.95
Nurse Practitioner $338.95
Veronica Mcfarlane, Apnp, APNP
Nurse Practitioner — Payments: $143.30
Nurse Practitioner $143.30
Sarah Reveal, Apnp, APNP
Nurse Practitioner — Payments: $44.14
Nurse Practitioner $44.14